Turner Heather D — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Turner Heather D has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.

Profile

Heather D. Turner is the Chief Executive Officer of LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company focused on developing therapies for neuropsychiatric diseases. She has also held a similar role at Terns Pharmaceuticals, Inc.

Board memberships

• LB Pharmaceuticals Inc
• Terns Pharmaceuticals, Inc.

Awards & honors

• Leadership in biopharmaceutical development
• CEO of LB Pharmaceuticals Inc
• Experience in neuropsychiatric drug development

Companies — Last 90 Days

• Terns Pharmaceuticals, Inc. (TERN) — 1 filings, last 2026-05-05
• Avalyn Pharma Inc. (AVLN) — 1 filings, last 2026-05-01

Frequently Asked Questions

Who is Turner Heather D?

Heather D. Turner is the Chief Executive Officer of LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company focused on developing therapies for neuropsychiatric diseases. She has also held a similar role at Terns Pharmaceuticals, Inc.…

How many SEC Form 4 filings has Turner Heather D submitted recently?

2 primary Form 4 filings in the last 90 days, covering 2 companies.

Where can I see all of Turner Heather D's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week